Hematology TimesEngland’s Cancer Drugs Fund raises concernsMarch 6, 2014Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaPharmacyRelated Issues
Hematology TimesDrugs get orphan designation for AML, MMMarch 4, 2014Leukemia, Myelodysplasia, TransplantationMultiple MyelomaPharmacyAML
Hematology TimesOmacetaxine mepesuccinate gets full FDA approvalFebruary 16, 2014Leukemia, Myelodysplasia, TransplantationPharmacyCML
Hematology TimesFDA again rejects rivaroxaban for use in ACS patientsFebruary 15, 2014ThrombosisPharmacy
Hematology TimesFDA approves ibrutinib for previously treated CLLFebruary 13, 2014Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersPharmacy
Hematology TimesExperts offer guidance for preventing drug shortagesFebruary 6, 2014PediatricsPharmacy
Hematology TimesIbrutinib trial stopped earlyJanuary 27, 2014Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersPharmacy
Hematology TimesStudy explains why FDA rejects new drug applicationsJanuary 23, 2014PharmacyRelated Issues
Hematology TimesFDA doesn’t hold drug trials to same standardsJanuary 22, 2014AnemiaPharmacyRelated Issues
Hematology TimesBrentuximab vedotin approved in JapanJanuary 22, 2014Lymphoma & Plasma Cell DisordersPharmacyHodgkin Lymphoma
